16:45 EDT Terns Pharmaceuticals (TERN) files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TERN:
- Biotech Alert: Searches spiking for these stocks today
- Terns Pharmaceuticals management to meet with Oppenheimer
- Promising Clinical Trials and Strong Financials Drive Buy Rating for Terns Pharmaceuticals
- Terns Pharmaceuticals Reports 2024 Progress and Outlook
- Terns Pharmaceuticals: Promising Investment with Strong Financials and Strategic Developments